A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)
Clinical trial NCT02586857 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02586857
- Sponsor
- Acerta Pharma BV
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-25
- Primary completion
- 2020-06-26
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.